ELRIG Drug Discovery 2025 Conference

Harness’ Laura Heraty, Sinem (Nursabah) Atli, PhD, Fay Humphries, Darci Bird, and Izzy Thurston are heading to Liverpool for the ELRIG Drug Discovery 2025 Conference, to connect with experts across the life sciences field.

We’re excited to engage with the innovative science being showcased at hashtag#ELRIG and share insights on our MISBA® and MISBA® Duo platforms, unlocking previously undruggable targets in neurodegenerative diseases. Looking forward to connecting with partners and peers driving the future of drug discovery.

Our programmes

Huntington's Disease

Discover more

ALS and Alzheimer's

Discover more

Our news

February 2026

Harness Therapeutics Nominates HRN001, a First-in-Class Drug Candidate for Huntington’s Disease and Establishes Clinical Advisory Board

October 2025

Harness Therapeutics Announces Launch of MISBA® Duo Platform and Research Collaboration with Ono Venture Investment

June 2025

Harness Therapeutics Publishes HTT CAG Repeat Sizing Methodology Code on GitHub

February 2025

Harness Therapeutics to Present Nanopore Sequencing Data for Detecting CAG Expansion in the Huntingtin Gene at CHDI Huntington’s Disease Therapeutics Conference

View all